Literature DB >> 28688465

Chronic Obstructive Pulmonary Disease Phenotypes: Implications for Care.

Shireen Mirza1, Roberto Benzo2.   

Abstract

Chronic obstructive pulmonary disease (COPD) phenotyping can help define clusters of patients with common characteristics that relate to clinically meaningful outcomes. In this review, we describe 7 clinically meaningful COPD phenotypes that can be identified by primary care physicians as well as specialists and that have specific management and prognostic implications: (1) asthma-COPD overlap phenotype, (2) frequent exacerbator phenotype, (3) upper lobe-predominant emphysema phenotype, (4) rapid decliner phenotype, (5) comorbid COPD phenotype, (6) physical frailty phenotype, and (7) emotional frailty phenotype.
Copyright © 2017 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28688465      PMCID: PMC5587116          DOI: 10.1016/j.mayocp.2017.03.020

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  37 in total

Review 1.  The Asthma-COPD Overlap Syndrome.

Authors:  Dirkje S Postma; Klaus F Rabe
Journal:  N Engl J Med       Date:  2015-09-24       Impact factor: 91.245

Review 2.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

Review 3.  Diagnostic test accuracy of simple instruments for identifying frailty in community-dwelling older people: a systematic review.

Authors:  Andrew Clegg; Luke Rogers; John Young
Journal:  Age Ageing       Date:  2014-10-29       Impact factor: 10.668

Review 4.  Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).

Authors:  Samantha C Herath; Phillippa Poole
Journal:  Cochrane Database Syst Rev       Date:  2013-11-28

5.  Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.

Authors:  Peter Lange; Yunus Çolak; Truls Sylvan Ingebrigtsen; Jørgen Vestbo; Jacob Louis Marott
Journal:  Lancet Respir Med       Date:  2016-04-06       Impact factor: 30.700

6.  The Frequency of Frailty in Ambulatory Patients With Chronic Lung Diseases.

Authors:  Neha Mittal; Rishi Raj; Ebtesam Attaya Islam; Kenneth Nugent
Journal:  J Prim Care Community Health       Date:  2015-09-02

Review 7.  Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review.

Authors:  Alison Pooler; Roger Beech
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-03-29

Review 8.  Asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): structured literature review and physician insights.

Authors:  B Ding; A Enstone
Journal:  Expert Rev Respir Med       Date:  2016-02-15       Impact factor: 3.772

9.  The impact of coping on the somatic and mental status of patients with COPD: a cross-sectional study.

Authors:  Ion Papava; Cristian Oancea; Virgil Radu Enatescu; Ana Cristina Bredicean; Liana Dehelean; Radu Stefan Romosan; Bogdan Timar
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-06-20

Review 10.  Roflumilast: a review of its use in the treatment of COPD.

Authors:  Jadwiga A Wedzicha; Peter Ma Calverley; Klaus F Rabe
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-01-06
View more
  24 in total

Review 1.  QSAR without borders.

Authors:  Eugene N Muratov; Jürgen Bajorath; Robert P Sheridan; Igor V Tetko; Dmitry Filimonov; Vladimir Poroikov; Tudor I Oprea; Igor I Baskin; Alexandre Varnek; Adrian Roitberg; Olexandr Isayev; Stefano Curtarolo; Denis Fourches; Yoram Cohen; Alan Aspuru-Guzik; David A Winkler; Dimitris Agrafiotis; Artem Cherkasov; Alexander Tropsha
Journal:  Chem Soc Rev       Date:  2020-05-01       Impact factor: 54.564

2.  Novel Thoracic MRI Approaches for the Assessment of Pulmonary Physiology and Inflammation.

Authors:  Jonathan P Brooke; Ian P Hall
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Chronic obstructive pulmonary disease classification, phenotypes and risk assessment.

Authors:  Prasad Manian
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

4.  Inspiratory pre-motor potentials during quiet breathing in ageing and chronic obstructive pulmonary disease.

Authors:  David A T Nguyen; Claire L Boswell-Ruys; Rachel A McBain; Danny J Eckert; Simon C Gandevia; Jane E Butler; Anna L Hudson
Journal:  J Physiol       Date:  2018-07-29       Impact factor: 5.182

Review 5.  Phenotypes of osteoarthritis: current state and future implications.

Authors:  Leticia A Deveza; Amanda E Nelson; Richard F Loeser
Journal:  Clin Exp Rheumatol       Date:  2019-10-15       Impact factor: 4.473

Review 6.  Pulmonary function testing in COPD: looking beyond the curtain of FEV1.

Authors:  Sotirios Kakavas; Ourania S Kotsiou; Fotis Perlikos; Maria Mermiri; Georgios Mavrovounis; Konstantinos Gourgoulianis; Ioannis Pantazopoulos
Journal:  NPJ Prim Care Respir Med       Date:  2021-05-07       Impact factor: 2.871

7.  Age- and gender-based comorbidity categories in general practitioner and pulmonology patients with COPD.

Authors:  Su-Jong Kim-Dorner; Torben Schmidt; Alexander Kuhlmann; Johann-Matthias Graf von der Schulenburg; Tobias Welte; Heidrun Lingner
Journal:  NPJ Prim Care Respir Med       Date:  2022-05-02       Impact factor: 2.871

8.  Frequency of Blood Eosinophilia in newly diagnosed Chronic Obstructive Pulmonary Disease patients.

Authors:  Ghulam Maqtada Khan; Faisal Faiyaz Zuberi; Syeda Bizat Uz Zahra; Lubna Ghafoor
Journal:  Pak J Med Sci       Date:  2020 May-Jun       Impact factor: 1.088

9.  The Impact of Sepsis on the Outcomes of COPD Patients: A Population-Based Cohort Study.

Authors:  Cheng-Hsin Chen; Chih-Cheng Lai; Ya-Hui Wang; Cheng-Yi Wang; Hao-Chien Wang; Chong-Jen Yu; Likwang Chen
Journal:  J Clin Med       Date:  2018-10-27       Impact factor: 4.241

10.  Development and multimodal characterization of an elastase-induced emphysema mouse disease model for the COPD frequent bacterial exacerbator phenotype.

Authors:  Irene Rodríguez-Arce; Xabier Morales; Mikel Ariz; Begoña Euba; Nahikari López-López; Maider Esparza; Derek W Hood; José Leiva; Carlos Ortíz-de-Solórzano; Junkal Garmendia
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.